Does BINIMETINIB Cause Interstitial lung disease? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Interstitial lung disease have been filed in association with BINIMETINIB (MEKTOVI). This represents 0.6% of all adverse event reports for BINIMETINIB.
42
Reports of Interstitial lung disease with BINIMETINIB
0.6%
of all BINIMETINIB reports
13
Deaths
22
Hospitalizations
How Dangerous Is Interstitial lung disease From BINIMETINIB?
Of the 42 reports, 13 (31.0%) resulted in death, 22 (52.4%) required hospitalization, and 6 (14.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for BINIMETINIB.
What Other Side Effects Does BINIMETINIB Cause?
Off label use (902)
Death (719)
Nausea (657)
Fatigue (562)
Diarrhoea (521)
Product use in unapproved indication (508)
Pyrexia (490)
Neoplasm progression (387)
Vomiting (375)
Rash (360)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BINIMETINIB Alternatives Have Lower Interstitial lung disease Risk?
BINIMETINIB vs BIOFLAVONOIDS
BINIMETINIB vs BIOTIN
BINIMETINIB vs BIPERIDEN
BINIMETINIB vs BIRCH TRITERPENES
BINIMETINIB vs BISACODYL